Multiple system atrophy (MSA) is a progressive disorder with limited treatment options. However, recent research has yielded potential developments into new therapeutic approaches. Current efforts centers on addressing the underlying pathophysiology of MSA. One avenue under investigation involves therapeutic interventions to regulate the activity